The American Cancer Society is hosting a series of mini-symposia on the epithelial–mesenchymal transition, engineered effector cells for immunotherapy, and other cancer research topics. All mini-symposia will feature a “3 short talks and a Q&A” format, with an emphasis on promoting a rich discussion among participants.
RSVP to firstname.lastname@example.org for further details and Zoom links.
"Not Cadherin to the Rules: New implications of EMT for development, metastasis, and cancer therapy"
Tuesday, April 20, 2021 – 1:00 to 3:00 p.m. EDT
- Lisa Taneyhill, PhD, Professor, University of Maryland
- Alison Obr, PhD, Postdoctoral Fellow, Rutgers, The State University of New Jersey
- Cai Roberts, PhD, Postdoctoral Associate, Yale University
"Engineered Effector Cells for Cancer Immunotherapy"
Tuesday, May 18, 2021 – 1:00 to 3:00 p.m. EDT
- Kristin Anderson, PhD, Postdoctoral Fellow, Fred Hutchinson Cancer Research Center
- Andras Heczey, MD, Assistant Professor, Pediatrics-Oncology, Baylor College of Medicine
- Christian Capitini, MD, Associate Professor, Pediatrics, University of Wisconsin-Madison